AU2003267026A1 - Hb-954 as a target for modulating angiogenesis - Google Patents

Hb-954 as a target for modulating angiogenesis

Info

Publication number
AU2003267026A1
AU2003267026A1 AU2003267026A AU2003267026A AU2003267026A1 AU 2003267026 A1 AU2003267026 A1 AU 2003267026A1 AU 2003267026 A AU2003267026 A AU 2003267026A AU 2003267026 A AU2003267026 A AU 2003267026A AU 2003267026 A1 AU2003267026 A1 AU 2003267026A1
Authority
AU
Australia
Prior art keywords
target
modulating angiogenesis
angiogenesis
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003267026A
Inventor
Katharine H. Dixon
Gene Liau
Cynthia Serdikoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2003267026A1 publication Critical patent/AU2003267026A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003267026A 2002-08-30 2003-08-29 Hb-954 as a target for modulating angiogenesis Abandoned AU2003267026A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40706302P 2002-08-30 2002-08-30
US60/407,063 2002-08-30
PCT/EP2003/009619 WO2004024763A1 (en) 2002-08-30 2003-08-29 Hb-954 as a target for modulating angiogenesis

Publications (1)

Publication Number Publication Date
AU2003267026A1 true AU2003267026A1 (en) 2004-04-30

Family

ID=31993944

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003267026A Abandoned AU2003267026A1 (en) 2002-08-30 2003-08-29 Hb-954 as a target for modulating angiogenesis

Country Status (2)

Country Link
AU (1) AU2003267026A1 (en)
WO (1) WO2004024763A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220135983A1 (en) * 2019-02-22 2022-05-05 Kyushu University, National University Corporation Prevention or treatment of fibrotic disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064872A2 (en) * 2000-02-29 2001-09-07 Millennium Pharmaceuticals, Inc. Gene 2465: methods and compositions for the diagnosis and treatment of cardiovascular, hepatic and bone disease

Also Published As

Publication number Publication date
WO2004024763A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
AUPS309002A0 (en) A covertile for a substrate
IL206078A0 (en) A labeled target
AU2003299531A1 (en) Compounds for modulating rna interference
AU2003266949A1 (en) Compounds
AU2003270001A1 (en) Syncrhonization techniques for a wireless system
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003279366A1 (en) Novel compounds
AU2003283896A1 (en) System for spraying a fluid material
AU2003251968A1 (en) A method for the modulation of angiogenesis
AU2003285019A1 (en) A system
AU2002345509A1 (en) A pressurisation system
AU2003224712A1 (en) Modulating angiogenesis
AU2003208404A1 (en) A couplig
AU2003218170A1 (en) Autoinducer compounds
EP1646834A1 (en) Condensor
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2002349521A1 (en) A composition comprising phytospingosine derivatives for apoptosis induction
AU2003208462A1 (en) Control for a tunable laser
AU2002952221A0 (en) A beam
AU2003223855A1 (en) Method for operating a call-centre
AU2003267026A1 (en) Hb-954 as a target for modulating angiogenesis
AU2003207991A1 (en) A conning tower construction
AU2003292667A1 (en) Benzocycloheptapyridine compounds
AU2003215256A1 (en) Control procedure selection
AU2003255322A1 (en) Compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase